Skip to main content
. 2016 Jun 16;7(30):47985–47997. doi: 10.18632/oncotarget.10103

Figure 3. Knocking down FOXM1 expression in human EOC cells reduces tumorigenic properties.

Figure 3

A. representative photographs of mice from each group injected with A2780-control or A2780-shFOXM1 cells. B. Tumor volumes were calculated after injection every 7 days. C. Tumor weight derived from FOXM1-shRNA knockdown or control-shRNA knockdown was measured at day 28. D-F. the expression levels of FOXM1, GLUT1 and HK2 were analyzed by qRT–PCR, western blotting and immunohistochemistry. Scale bar represents 100 μm. Data are represented as means ± SD of each group. *P < 0.05, **P < 0.01, ***P < 0.001 by Student's t-test.